Sox9 accelerates vascular ageing by regulating extracellular matrix composition and stiffness

Rationale Vascular calcification and increased extracellular matrix (ECM) stiffness are hallmarks of vascular ageing. Sox9 (SRY-Box Transcription Factor 9) is a master regulator of chondrogenesis, also expressed in the vasculature, that has been implicated in vascular smooth muscle cell (VSMC) osteo-chondrogenic conversion. Objective Here, we investigated the relationship between vascular ageing, calcification and Sox9-driven ECM regulation in VSMCs. Methods and Results Immunohistochemistry in human aortic samples showed that Sox9 was not spatially associated with vascular calcification but correlated with the senescence marker p16. Analysis of Sox9 expression in vitro showed it was mechanosensitive with increased expression and nuclear translocation in senescent cells and on stiff matrices. Manipulation of Sox9 via overexpression and depletion, combined with atomic force microscopy (AFM) and proteomics, revealed that Sox9 regulates ECM stiffness and organisation by orchestrating changes in collagen expression and reducing VSMC contractility, leading to the formation of an ECM that mirrored that of senescent cells. These ECM changes promoted phenotypic modulation of VSMCs whereby senescent cells plated onto ECM synthesized from cells depleted of Sox9 returned to a proliferative state, while proliferating cells on a matrix produced by Sox9 expressing cells showed reduced proliferation and increased DNA damage, reiterating features of senescent cells. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (LH3) was identified as a Sox9 target, and key regulator of ECM stiffness. LH3 is packaged into extracellular vesicles (EVs) and Sox9 promoted EV secretion, leading to increased LH3 deposition within the ECM. Conclusions These findings identify cellular senescence and Sox9 as a key regulators of ECM stiffness during VSMC ageing and highlight a crucial role for ECM structure and composition in regulating VSMC phenotype. We identify a positive feedback cycle whereby cellular senescence and increased ECM stiffening promote Sox9 expression which drives further ECM modifications that act to accelerate vascular stiffening and cellular senescence.

[1]  M. Mayr,et al.  Vascular smooth muscle cell senescence accelerates medin aggregation via small extracellular vesicle secretion and extracellular matrix reorganization , 2022, Aging cell.

[2]  C. Mas-Bargues,et al.  The Contribution of Extracellular Vesicles From Senescent Endothelial and Vascular Smooth Muscle Cells to Vascular Calcification , 2022, Frontiers in Cardiovascular Medicine.

[3]  A. Mammoto,et al.  Extracellular Matrix in Aging Aorta , 2022, Frontiers in Cell and Developmental Biology.

[4]  M. Mayr,et al.  Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling , 2021, Circulation.

[5]  Q. Cui,et al.  Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling , 2021, Circulation.

[6]  Stefania Marcotti,et al.  A workflow for rapid unbiased quantification of fibrillar feature alignment in biological images , 2021, bioRxiv.

[7]  H. C. Beck,et al.  Basement membrane collagen IV deficiency promotes abdominal aortic aneurysm formation , 2021, Scientific Reports.

[8]  Li-Hong Peng,et al.  Molecular Mechanisms of Chondrocyte Proliferation and Differentiation , 2021, Frontiers in Cell and Developmental Biology.

[9]  L. Schurgers,et al.  Proteoglycan 4 Modulates Osteogenic Smooth Muscle Cell Differentiation during Vascular Remodeling and Intimal Calcification , 2021, Cells.

[10]  P. Jat,et al.  Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype , 2021, Frontiers in Cell and Developmental Biology.

[11]  R. Hayward,et al.  Runx2 (Runt-Related Transcription Factor 2) Links the DNA Damage Response to Osteogenic Reprogramming and Apoptosis of Vascular Smooth Muscle Cells. , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[12]  C. Bishop,et al.  The Bright and Dark Side of Extracellular Vesicles in the Senescence-Associated Secretory Phenotype. , 2020, Mechanisms of ageing and development.

[13]  D. Towler,et al.  DNA Damage Response , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[14]  R. Luque,et al.  Microvesicles from indoxyl sulfate-treated endothelial cells induce vascular calcification in vitro , 2020, Computational and structural biotechnology journal.

[15]  Hanna J. Sanyour,et al.  Extracellular Matrix Proteins and Substrate Stiffness Synergistically Regulate Vascular Smooth Muscle Cell Migration and Cortical Cytoskeleton Organization. , 2020, ACS applied bio materials.

[16]  C. Shanahan,et al.  Arterial “inflammaging” drives vascular calcification in children on dialysis , 2019, Kidney international.

[17]  Yang Gao,et al.  PI3Kγ promotes vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis via a SOX9-dependent mechanism , 2018, EBioMedicine.

[18]  R. Strasser,et al.  Sox9 is increased in arterial plaque and stenosis, associated with synthetic phenotype of vascular smooth muscle cells and causes alterations in extracellular matrix and calcification. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[19]  A. Durham,et al.  Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness , 2018, Cardiovascular research.

[20]  V. Lefebvre,et al.  SOX9 and the many facets of its regulation in the chondrocyte lineage , 2017, Connective tissue research.

[21]  C. Shanahan,et al.  Prelamin A Accumulation Attenuates Rac1 Activity and Increases the Intrinsic Migrational Persistence of Aged Vascular Smooth Muscle Cells , 2016, Cells.

[22]  M. Wallingford,et al.  Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation. , 2016, Cardiovascular research.

[23]  M. Girolami,et al.  Regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis , 2016, Nature Communications.

[24]  L. Martiny,et al.  Matrix ageing and vascular impacts: focus on elastin fragmentation. , 2016, Cardiovascular research.

[25]  Guoping Chen,et al.  Decellularized Extracellular Matrix as an In Vitro Model to Study the Comprehensive Roles of the ECM in Stem Cell Differentiation , 2015, Stem cells international.

[26]  H. Donninger,et al.  Fibroblast-Derived Extracellular Matrices: An Alternative Cell Culture System That Increases Metastatic Cellular Properties , 2015, PloS one.

[27]  Guanwei Fan,et al.  Circumferentially aligned fibers guided functional neoartery regeneration in vivo. , 2015, Biomaterials.

[28]  A. McMahon,et al.  Distinct Transcriptional Programs Underlie Sox9 Regulation of the Mammalian Chondrocyte. , 2015, Cell reports.

[29]  M. Pellegrini,et al.  Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells. , 2014, Developmental cell.

[30]  S. Liang,et al.  SOX9 Regulates Multiple Genes in Chondrocytes, Including Genes Encoding ECM Proteins, ECM Modification Enzymes, Receptors, and Transporters , 2014, PloS one.

[31]  C. St. Hilaire,et al.  Medial vascular calcification revisited: review and perspectives. , 2014, European heart journal.

[32]  T. Abe,et al.  An analysis of skeletal development in osteoblast‐specific and chondrocyte‐specific runt‐related transcription factor‐2 (Runx2) knockout mice , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Fiona M. Watt,et al.  Role of the extracellular matrix in regulating stem cell fate , 2013, Nature Reviews Molecular Cell Biology.

[34]  I. Drozdov,et al.  Prelamin A Accelerates Vascular Calcification Via Activation of the DNA Damage Response and Senescence-Associated Secretory Phenotype in Vascular Smooth Muscle Cells , 2013, Circulation research.

[35]  Yong Sun,et al.  Smooth Muscle Cell–Specific Runx2 Deficiency Inhibits Vascular Calcification , 2012, Circulation research.

[36]  Veena V. Naik,et al.  Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. , 2012, Cardiovascular research.

[37]  Jiliang Zhou,et al.  SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation. , 2012, Biochemical and biophysical research communications.

[38]  M. Mayr,et al.  Calcium Regulates Key Components of Vascular Smooth Muscle Cell–Derived Matrix Vesicles to Enhance Mineralization , 2011, Circulation research.

[39]  A. Cheng,et al.  SOX9 determines RUNX2 transactivity by directing intracellular degradation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[41]  H. Matsubara,et al.  Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. , 2009, American journal of physiology. Heart and circulatory physiology.

[42]  D. Dichek,et al.  Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries , 2009, Circulation research.

[43]  H. Cox,et al.  A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene. , 2008, American journal of human genetics.

[44]  T. Gridley.  Notch signaling in vascular development and physiology , 2007, Development.

[45]  Chunguang Wang,et al.  Expanding the lysyl hydroxylase toolbox: New insights into the localization and activities of lysyl hydroxylase 3 (LH3) , 2007, Journal of cellular physiology.

[46]  E. Cukierman,et al.  Preparation of Extracellular Matrices Produced by Cultured and Primary Fibroblasts , 2006, Current protocols in cell biology.

[47]  R. Sormunen,et al.  Lysyl hydroxylase 3 (LH3) modifies proteins in the extracellular space, a novel mechanism for matrix remodeling , 2006, Journal of cellular physiology.

[48]  Y. Bobryshev.  Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification , 2005, The Journal of pathology.

[49]  F. Beier,et al.  RhoA/ROCK Signaling Regulates Sox9 Expression and Actin Organization during Chondrogenesis* , 2005, Journal of Biological Chemistry.

[50]  L. Schurgers,et al.  Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. , 2004, Journal of the American Society of Nephrology : JASN.

[51]  P. Weissberg,et al.  Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[52]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[53]  M. Fishbein,et al.  Genetic determination of cartilaginous metaplasia in mouse aorta. , 1995, Arteriosclerosis, thrombosis, and vascular biology.